España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Anixa Biosciences
ANIX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.98
0.17
5.87%
At close: -
$3.03
0.05
1.85%
After Hours: 4:37 PM EDT
Get Report
Comment
Anixa Biosciences (ANIX) Forecast
News
Earnings
Anixa Biosciences (ANIX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Anixa Biosciences (NASDAQ:ANIX) Stock
Anixa Biosciences Stock (NASDAQ: ANIX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 22, 2025
Anixa Biosciences shares are trading higher. ...
Benzinga Newsdesk
D. Boral Capital Maintains Buy on Anixa Biosc...
Benzinga Newsdesk
Tuesday, January 21, 2025
Anixa Biosciences shares are trading higher a...
Benzinga Newsdesk
Anixa Biosciences Highlights 2024 Achievement...
Benzinga Newsdesk
Tuesday, January 14, 2025
D. Boral Capital Maintains Buy on Anixa Biosc...
Benzinga Newsdesk
Friday, November 22, 2024
Anixa Biosciences shares are trading higher a...
Benzinga Newsdesk
Anixa Biosciences Approves Bitcoin Purchase A...
Benzinga Newsdesk
Tuesday, November 19, 2024
D. Boral Capital Maintains Buy on Anixa Biosc...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Anixa B...
Benzinga Newsdesk
Monday, November 18, 2024
Anixa Biosciences Initiates Dosing In The Thi...
Benzinga Newsdesk
Monday, November 11, 2024
D. Boral Capital Maintains Buy on Anixa Biosc...
Benzinga Newsdesk
Friday, November 08, 2024
Anixa Biosciences And Cleveland Clinic Presen...
Benzinga Newsdesk
Wednesday, November 06, 2024
Anixa Biosciences Sets November 8 For Public ...
Benzinga Newsdesk
Wednesday, October 30, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, October 15, 2024
Anixa Biosciences Administers Second Dose To ...
Benzinga Newsdesk
Monday, September 30, 2024
EF Hutton Maintains Buy on Anixa Biosciences,...
Benzinga Newsdesk
Anixa Biosciences Submits Amendment To Protoc...
Benzinga Newsdesk
Tuesday, September 24, 2024
EF Hutton Maintains Buy on Anixa Biosciences,...
Benzinga Newsdesk
Anixa Biosciences Announces Phase 2 Study Pla...
Benzinga Newsdesk
Wednesday, September 18, 2024
Anixa Biosciences To Present At International...
Benzinga Newsdesk
Tuesday, September 17, 2024
HC Wainwright & Co. Reiterates Buy on Anixa B...
Benzinga Newsdesk
Monday, September 09, 2024
EF Hutton Maintains Buy on Anixa Biosciences,...
Benzinga Newsdesk
Tuesday, September 03, 2024
Anixa Biosciences Presents Ovarian Cancer CAR...
Benzinga Newsdesk
Wednesday, August 07, 2024
EF Hutton Initiates Coverage On Anixa Bioscie...
Benzinga Newsdesk
Monday, July 29, 2024
Anixa Biosciences To Presentation Its Ovarian...
Benzinga Newsdesk
Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying
Avi Kapoor
Wednesday, July 24, 2024
HC Wainwright & Co. Reiterates Buy on Anixa B...
Benzinga Newsdesk
Tuesday, July 23, 2024
EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy
Vandana Singh
EXCLUSIVE: Anixa Biosciences Tells Benzinga '...
Benzinga Newsdesk
EXCLUSIVE: Anixa Biosciences Tells Benzinga C...
Benzinga Newsdesk
Wednesday, July 17, 2024
Anixa Biosciences Collaborator, Cleveland Cli...
Benzinga Newsdesk
Monday, July 15, 2024
EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program
Anusuya Lahiri
EXCLUSIVE: Anixa Biosciences Tells Benzinga C...
Benzinga Newsdesk
Monday, June 24, 2024
Anixa Biosciences Treats Sixth Patient In Ong...
Benzinga Newsdesk
Monday, June 10, 2024
HC Wainwright & Co. Maintains Buy on Anixa Bi...
Benzinga Newsdesk
Tuesday, May 21, 2024
Anixa Biosciences Begins Treatment Of Fifth P...
Benzinga Newsdesk
Wednesday, May 08, 2024
Anixa Biosciences Partners With Cleveland Cli...
Benzinga Newsdesk
Friday, May 03, 2024
Anixa Biosciences 13D Filing Shows President,...
Benzinga Newsdesk
Thursday, March 21, 2024
HC Wainwright & Co. Reiterates Buy on Anixa B...
Benzinga Newsdesk
Tuesday, March 12, 2024
Recap: Anixa Biosciences Q1 Earnings
Benzinga Insights
Tuesday, February 13, 2024
HC Wainwright & Co. Reiterates Buy on Anixa B...
Benzinga Newsdesk
Monday, February 12, 2024
Anixa Biosciences Initiates Dosing in Second ...
Benzinga Newsdesk
Tuesday, January 23, 2024
Anixa Biosciences Announces Japanese Patent O...
Benzinga Newsdesk
Wednesday, December 20, 2023
Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?
Kimberly Adams
Thursday, December 07, 2023
Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations'
Vandana Singh
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Anixa B...
Benzinga Newsdesk
Wednesday, December 06, 2023
Anixa Biosciences And Cleveland Clinic Presen...
Benzinga Newsdesk
Anixa Biosciences To Host Conference Call Thi...
Benzinga Newsdesk
Monday, November 27, 2023
Anixa Biosciences Announces European Patent O...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
